Low Float Biotech Stock. Huge Potential. The Setup Is Here

The Setup Is Here. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  

You are receiving this email because you are subscribed to Morning Watchlist from Behind the Markets. If you no longer wish to receive these partner emails, please unsubscribe here. This message is from SmallCaps Daily. NanoViricides, Inc. (NYSE: NNVC) is a clinical-stage biotech company working on a broad-spectrum antiviral drug platform that could address multiple billion-dollar unmet needs — including RSV, COVID, Bird Flu, and now measles. Here’s why we’re watching it closely: - NNVC recently surged to a 6 month high - Public float under 16M shares = room for big swings - Recently broke through major technical indicators — and triggered bullish signals per Trading View technicals - NV-387 recently entered Phase II trials per a May 14 disclosure - Stanford research shows measles could become endemic — NNVC is now testing a potential treatment - Sub-$30M market cap leaves tons of room for value appreciation if even one viral target succeeds We look for setups with real science, big market needs, and technical momentum — and NNVC is checking every box. Biotech names like this often go unnoticed… until they don’t. Whether or not broader markets turn, pandemics and public health threats aren’t waiting — and NNVC is aiming straight at the front lines with a novel platform. With recent momentum, multiple viral targets, and an unusually tight float, NanoViricides (NNVC) is one biotech to watch immediately. 🧬 Why NNVC Could Be a 2025 Biotech Sleeper Hit Our mailing address is: Behind the Markets, LLC 4260 NW 1st Avenue, Suite 55 Boca Raton, FL 33431 We are issuing this disclosure in compliance with Section 17(b) of the Securities Act, which requires us to disclose any compensation received or expected to be received in cash or in kind in connection with the purchase or sale of any security. We would like to inform you that we have received or expect to receive compensation in connection with the purchase or sale of the securities of NanoViricides, Inc. (NYSE American: NNVC). The compensation consists of up to $5,500 and was received/will be received from Interactive Offers. This compensation should not be considered as an endorsement of the securities of adviser NanoViricides, Inc. (NYSE American: NNVC) and we are not responsible for any errors or omissions in any information provided about the securities of NanoViricides, Inc. (NYSE American: NNVC) and Interactive Offers. We encourage you to conduct your own due diligence and research before making any investment decisions. You should also consult with a financial advisor before making any investment decisions. This disclosure is made as of 06/13/2025. Behind the Markets Copyright © 2024 Behind the Markets, LLC, All rights reserved. You're receiving this email as part of your subscription to Behind the Markets. For more information about our privacy practices, please review our Privacy Policy or our Legal Notices. You are receiving this email because you are subscribed to Morning Watchlist from Behind the Markets. If you no longer wish to receive these partner emails, please unsubscribe here.   Today's Featured Pick: Copper just hit a 10-year high and this could be the perfect play! We are issuing this disclosure in compliance with Section 17(b) of the Securities Act, which requires us to disclose any compensation received or expected to be received in cash or in kind in connection with the purchase or sale of any security. We would like to inform you that we have received or expect to receive compensation in connection with the purchase or sale of the securities of NexMetals Mining Corp. (TSXV:NEXM) (OTC:NEXM). The compensation consists of up to $6,000 and was received/will be received from Market Jar Media.  This compensation should not be considered as an endorsement of the securities of adviser NexMetals Mining Corp. (TSXV:NEXM) (OTC:NEXM) and we are not responsible for any errors or omissions in any information provided about the securities of NexMetals Mining Corp. by Trading Whisperer or Market Jar Media. We encourage you to conduct your own due diligence and research before making any investment decisions. You should also consult with a financial advisor before making any investment decisions. This disclosure is made as of 06/13/2025.